Form 8-K - Current report:
SEC Accession No. 0000320017-23-000021
Filing Date
2023-05-01
Accepted
2023-05-01 16:01:49
Documents
12
Period of Report
2023-05-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K clbs-20230501.htm   iXBRL 8-K 31250
  Complete submission text file 0000320017-23-000021.txt   171178

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clbs-20230501.xsd EX-101.SCH 1893
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clbs-20230501_lab.xml EX-101.LAB 25154
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clbs-20230501_pre.xml EX-101.PRE 13040
6 EXTRACTED XBRL INSTANCE DOCUMENT clbs-20230501_htm.xml XML 11073
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33650 | Film No.: 23873449
SIC: 8090 Services-Misc Health & Allied Services, NEC